11.2 Tolerance Tests & TDM Scheduling
Key Takeaways
- OGTT timing starts from completion of the glucose load; fasting baseline precedes the drink, and later draws follow the ordered interval schedule
- Patients must remain fasting (except the glucose dose) and typically at rest during OGTT; missed intervals can invalidate interpretation
- Trough TDM levels are drawn immediately before the next dose; peak levels are drawn after dosing at drug-specific times from the end of infusion or dose
- Always document exact draw time and relevant dose time information—results cannot be interpreted without the time relationship
- If a peak cannot be collected exactly on time, collecting slightly late with accurate documentation is usually better than collecting early
Quick Answer: For glucose tolerance tests, draw the fasting baseline, administer the ordered glucose load, then collect each timed specimen on the exact interval schedule while the patient stays fasting and at rest. For therapeutic drug monitoring, draw troughs just before the next dose and peaks at the drug-specific post-dose time—and record actual times so clinicians can interpret the level.
Domain III-C and III-D address tolerance testing and therapeutic drug monitoring (TDM) scheduling. These are the classic "clock-driven" collections where a technically perfect venipuncture still produces a useless result if the time is wrong. RPT candidates must know the sequencing, the documentation burden, and the coordination with nursing and pharmacy.
Oral Glucose Tolerance Testing (OGTT): Purpose and Preparation
An oral glucose tolerance test measures how the body handles a standardized glucose load. It is used in evaluating diabetes and impaired glucose tolerance, and related protocols appear in gestational diabetes testing. Exact dose and interval schedules are ordered by the provider and defined by laboratory procedure—always follow the order and procedure manual for that patient.
Typical preparation themes (confirm locally):
- Overnight fast (commonly at least 8 hours; often up to 16 hours maximum in classic protocols)—water is usually allowed; caloric intake is not.
- Usual carbohydrate intake in the days before testing when the protocol requires it.
- Morning testing preferred; the patient should remain seated/resting during the test when possible.
- Hold confounding factors per protocol (for example, smoking during the test is often restricted).
If the patient did not meet the fasting requirement, do not start the challenge until the provider or procedure allows an alternative plan. Starting an OGTT on a nonfasting patient wastes the appointment and produces misleading curves.
OGTT Collection Sequence
A standard adult diagnostic pattern uses a 75 g oral glucose load (pediatric dosing is weight-based with a maximum, commonly 1.75 g/kg up to 75 g). Many protocols sample as follows:
| Time point | What you collect | Notes |
|---|---|---|
| 0 min (baseline) | Fasting plasma glucose | Before any glucose drink |
| Glucose load | Patient drinks entire dose in the allowed few minutes | Timing usually starts when drinking is finished |
| 30 / 60 / 90 min | Timed glucoses if ordered | Not every protocol uses every interval |
| 120 min (2 hour) | Post-load glucose | Core diagnostic sample for many adult OGTTs |
| 180 min | Additional sample if the 100-g, 3-hour protocol is ordered | The diagnostic step of the gestational two-step approach |
The standard nonpregnant 75-g, 2-hour OGTT (per ADA) draws at 0 hours (fasting baseline) and 2 hours after ingestion. Variations exist: a 1-hour 50-g screen (gestational, often nonfasting) and a separate diagnostic 100-g, 3-hour test (fasting, 1, 2, and 3 hours) with different cutoffs and intervals are not the same workflow. Read the order: "1-hour glucola" is not the same as a "3-hour GTT."
Operational Rules That Protect Validity
- Draw baseline first, label it as fasting/0-hour.
- Administer the glucose beverage and note the finish time—this is your zero for subsequent intervals in most phlebotomy workflows.
- Set timers for each remaining draw; do not rely on memory during a busy morning.
- Keep the patient fasting except for the glucose dose until the test ends (no juice "because they feel shaky" unless a protocol-stopping adverse event occurs—then follow emergency/nursing guidance and document).
- Collect each interval into the correct tube (often gray-top fluoride for glucose stability—follow lab procedure) and label with the time point as well as patient identifiers.
- If a draw is late or early, document the actual time; large deviations may require provider notification or test invalidation per policy.
Adverse symptoms (vomiting the load, syncope, inability to continue) can abort the test. Notify the provider/nurse, document what was retained of the dose and which samples exist, and do not invent missing time points.
Therapeutic Drug Monitoring: Why Timing Is the Result
TDM measures drug concentration to guide dosing—efficacy, toxicity, compliance, and changes in organ function. For many drugs, the number on the report is meaningless without knowing whether it is a trough, peak, or random level and when the last dose was given.
| Level type | When to draw (general rule) | Purpose |
|---|---|---|
| Trough | Immediately prior to the next dose (often within ~30–60 minutes before, or IPTND) | Most reproducible for many drugs; reflects elimination |
| Peak | After the dose at a drug- and route-specific interval from end of infusion or administration | Reflects high concentration; dosing adequacy/toxicity risk |
| Random | As ordered when timing is less critical | Interpretation still needs dose history |
Representative Timing Patterns
Exact minutes vary by drug monograph and hospital protocol. Know these common patterns conceptually:
| Drug / class | Trough | Peak (typical teaching examples) |
|---|---|---|
| Aminoglycosides (gentamicin, tobramycin, amikacin) IV | ~30 min before next dose / IPTND | Often ~30 min after infusion ends (IM peaks later, e.g., ~1 hour) |
| Vancomycin IV | IPTND / ~30 min before dose | If ordered, often ~1 hour after infusion ends (many modern protocols emphasize troughs) |
| Digoxin | Trough/IPTND preferred; draw at least 6–8 hours after the dose | Distribution phase is long—levels drawn sooner are falsely high |
| Antiepileptics (e.g., phenytoin, carbamazepine, valproate) | Often trough/IPTND | Peaks vary widely by drug and formulation |
| Lithium | Trough drawn 12 hours after the last dose | The 12-hour post-dose level is the standard reference point; formulation affects peak timing |
You are not expected to memorize every pharmacokinetic table for the RPT, but you are expected to: (1) recognize peak vs trough on the order, (2) coordinate with nursing so doses are not given before a trough is drawn, (3) schedule peaks from the end of infusion when that is the rule, and (4) document times.
Coordinating With Nursing and Pharmacy
TDM failures are usually communication failures:
- Arrive for a trough to find the nurse already hung the antibiotic—now the level is not a trough. Do not relabel it as trough. Draw only if the provider wants a random level, and document the relationship to the dose.
- For peaks, confirm infusion start/end times before you start the clock.
- If you will be late for a trough, ask nursing to hold the dose until collection when clinically appropriate and ordered.
- Never draw TDM specimens from a line lumen used to infuse that same drug without following line-draw policy—contamination falsely elevates levels. Prefer a peripheral stick when required by procedure.
Documenting Draw Times
Documentation is part of the specimen:
- Record date and exact clock time of collection on the label/requisition/LIS prompt.
- Record or verify last dose time, dose amount, and whether the level is peak, trough, or random when the system requires it.
- If the ordered time was 09:00 and you collected at 09:12, write 09:12, not 09:00. Honest times let pharmacists interpret; fictional punctuality endangers dosing decisions.
- For OGTT, label each tube with the interval (0, 30, 60, 120, etc.) and actual time.
Guidance often cited for peaks you cannot hit exactly: collecting slightly late with accurate documentation is preferable to collecting early (still in distribution for some drugs). Always follow your laboratory's TDM collection guideline.
Putting III-C and III-D Into One Shift Story
Imagine 08:00: Patient A starts a 2-hour OGTT (baseline drawn, glucola finished 08:05 → 2-hour draw due 10:05). Patient B has a gentamicin trough due 08:25 before an 08:30 dose. Patient C has routine labs. Sequence: protect B's trough (and dose hold if needed), keep A's timers running, fit C around those anchors, return for A's 10:05 draw without letting anyone feed Patient A early. That is time management as clinical practice—not as abstract productivity.
Exam Traps for III-C and III-D
- Starting the OGTT clock when the drink is handed over instead of when ingestion is completed (follow your procedure—most timing keys off completion).
- Allowing snacks during OGTT.
- Drawing a trough after the dose and still calling it a trough.
- Drawing digoxin shortly after a dose and treating it as interpretable steady concentration.
- Omitting actual collection time on TDM or tolerance specimens.
- Collecting a peak from the infusion line without proper protocol, contaminating the sample.
Master the clock, the labels, and the handoffs. Tolerance tests and TDM are where organization becomes patient safety.
During a standard 2-hour 75 g OGTT, when is the fasting baseline specimen collected?
A vancomycin trough is ordered. The nurse is ready to hang the next dose. What should the phlebotomist ensure?
A standard 2-hour 75-gram oral glucose tolerance test (OGTT) requires draws at which time points?
Why must exact collection time be documented for TDM specimens?